We have data on 683 companies that use Ion Torrent. The companies using Ion Torrent are most often found in United States and in the Hospital & Health Care industry. Ion Torrent is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Ion Torrent usage goes back as far as 4 years and 4 months.
|Cancer Genetics Inc||cancergenetics.com||United States||10M-50M||200-500|
|Asuragen, Inc.||asuragen.com||United States||10M-50M||200-500|
|Biomarin Pharmaceutical Inc||bmrn.com||United States||>1000M||1000-5000|
|AbbVie Inc.||abbvie.com||United States||>1000M||>10000|
|University of Nevada-Reno||unr.edu||United States||200M-1000M||1000-5000|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Ion Torrent has a market share of about 0.7%. Other major and competing products in this category include:
Ion Torrent next-generation sequencing utilizes massively parallel sequencing to generate thousands of megabases of sequence information per day, opening doors to new research studies that were once difficult to accomplish in a practical manner. Powered by semiconductor chips, Ion Torrent sequencing technology is simpler, faster, and more cost-effective and scalable than other benchtop next-generation sequencing technologies.
Looking at Ion Torrent customers by industry, we find that Hospital & Health Care (23%), Higher Education (22%), Biotechnology (8%), Education Management (7%) and Research (6%) are the largest segments.
58% of Ion Torrent customers are in United States and 6% are in United Kingdom.